The TLR2/TLR4 agonist (Bacillus Calmette and Guérin) is the most effective TLR ligand in cancer therapy; it has been used to treat bladder cancer for more than thirty years [41]. This evidence concerns the gene TLR2 and urinary bladder carcinoma.